State of Wisconsin Investment Board
KALV

State of Wisconsin Investment Board’s KalVista Pharmaceuticals KALV Stock Holding History

State of Wisconsin Investment Board’s Portfolio KALV Stock Details KALV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$328K Buy
16,292
+369
+2% +$5.95K ﹤0.01% 2184
2025
Q4 		$257K Sell
15,923
-50,037
-76% -$663K ﹤0.01% 2210
2025
Q3 		$803K Sell
65,960
-7,383
-10% -$102K ﹤0.01% 1697
2025
Q2 		$829K Buy
73,343
+12,300
+20% +$150K ﹤0.01% 1650
2025
Q1 		$704K Sell
61,043
-4,705
-7% -$48K ﹤0.01% 1617
2024
Q4 		$557K Buy
65,748
+11,280
+21% +$117K ﹤0.01% 1759
2024
Q3 		$631K Sell
54,468
-6,287
-10% -$79.1K ﹤0.01% 1767
2024
Q2 		$716K Buy
60,755
+15,755
+35% +$184K ﹤0.01% 1665
2024
Q1 		$534K Sell
45,000
-6,100
-12% -$81.3K ﹤0.01% 1718
2023
Q4 		$626K Sell
51,100
-22,900
-31% -$208K ﹤0.01% 1597
2023
Q3 		$713K Sell
74,000
-14,600
-16% -$149K ﹤0.01% 1538
2023
Q2 		$797K Sell
88,600
-13,900
-14% -$128K ﹤0.01% 1560
2023
Q1 		$806K Sell
102,500
-15,800
-13% -$118K ﹤0.01% 1579
2022
Q4 		$800K Buy
118,300
+59,071
+100% +$316K ﹤0.01% 1624
2022
Q3 		$859K Sell
59,229
-15,171
-20% -$212K ﹤0.01% 1618
2022
Q2 		$732K Buy
74,400
+40,500
+119% +$447K ﹤0.01% 1848
2022
Q1 		$500K Buy
33,900
+12,500
+58% +$180K ﹤0.01% 1888
2021
Q4 		$283K Sell
21,400
-14,100
-40% -$224K ﹤0.01% 1999
2021
Q3 		$619K Buy
35,500
+3,600
+11% +$73K ﹤0.01% 1624
2021
Q2 		$764K Hold
31,900
– – ﹤0.01% 1542
2021
Q1 		$820K Buy
31,900
+11,600
+57% +$305K ﹤0.01% 1420
2020
Q4 		$385K Buy
+20,300
New +$348K ﹤0.01% 1610
2020
Q1 		– Sell
-17,500
Closed -$312K – 1713
2019
Q4 		$312K Hold
17,500
– – ﹤0.01% 1535
2019
Q3 		$203K Buy
+17,500
New +$283K ﹤0.01% 1501

Other funds holding KALV

VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State of Wisconsin Investment Board's KALV Position: Q1 2026 in Review

State of Wisconsin Investment Board increased its KalVista Pharmaceuticals (KALV) stake by 2.3% in Q1 2026, buying an estimated $5.95K and bringing the position to 16,292 shares worth $328K. The position accounts for ﹤0.01% of the portfolio, ranked #2184.

State of Wisconsin Investment Board first reported a position in KALV in Q3 2019 and has held it in 24 quarters since. The position peaked at $859K in Q3 2022. 184 funds tracked by Wall St. Rank hold KALV as of Q1 2026.

  • State of Wisconsin Investment Board held 16,292 shares of KalVista Pharmaceuticals worth $328K as of Q1 2026.
  • State of Wisconsin Investment Board bought 369 KalVista Pharmaceuticals shares in Q1 2026, an estimated $5.95K.
  • KalVista Pharmaceuticals made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #2184 holding.
  • State of Wisconsin Investment Board first reported a position in KalVista Pharmaceuticals in Q3 2019 and has held it in 24 quarters since.
  • State of Wisconsin Investment Board's KalVista Pharmaceuticals position peaked at $859K in Q3 2022.
  • 184 funds tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.